Trial Profile
Evaluation of efficacy of duloxetine and pregabalin in patients with painful diabetic peripheral neuropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2014
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 13 May 2014 New trial record
- 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.